Biomea Fusion (BMEA) Ownership - Who owns Biomea Fusion?
Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BMEA showed earnings on August 05, 2025. You can read more about the earnings report here.